샘플 요청 목록

 카트 문의
시장보고서
상품코드
1787235

세계의 NAD(Nicotinamide Adenine Dinucleotide) 시장

Nicotinamide Adenine Dinucleotide
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 276 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 NAD(Nicotinamide Adenine Dinucleotide) 시장은 2030년까지 14억 달러에 도달

2024년에 6억 8,310만 달러로 추정되는 세계의 NAD(Nicotinamide Adenine Dinucleotide) 시장은 분석 기간인 2024-2030년에 CAGR 13.3%로 성장하며, 2030년에는 14억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 식품 등급은 CAGR 14.8%를 기록하며, 분석 기간 종료시에는 8억 3,310만 달러에 달할 것으로 예측됩니다. 의약품 등급 부문의 성장률은 분석 기간 중 CAGR 12.0%로 추정됩니다.

미국 시장은 1억 8,610만 달러로 추정, 중국은 CAGR 18.1%로 성장 예측

미국의 NAD(Nicotinamide Adenine Dinucleotide) 시장은 2024년에는 1억 8,610만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 분석 기간인 2024-2030년의 CAGR을 18.1%로, 2030년까지 3억 1,080만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 9.6%와 12.0%로 예측됩니다. 유럽에서는 독일이 CAGR 10.6%로 성장할 것으로 예측됩니다.

세계 NAD(Nicotinamide Adenine Dinucleotide) 시장 - 주요 동향 및 촉진요인 정리

NAD(Nicotinamide Adenine Dinucleotide)가 건강 및 장수 연구에서 주목받는 이유

NAD(Nicotinamide Adenine Dinucleotide)는 세포 대사, 에너지 생산, DNA 복구에 필수적인 역할을 하므로 건강 및 웰니스 산업에서 중요한 분자로 부상하고 있습니다. NAD는 모든 생체 세포에 존재하는 보효소로서 미토콘드리아 기능, 산화 스트레스 반응, 세포 노화 과정의 조절에 중요한 역할을 합니다. 과학적 연구에 따르면 NAD 수치의 감소는 노화 및 노화 관련 질환과 관련이 있으며, 수명 연장 및 신진대사 건강 증진을 위한 NAD 강화 보충제, 치료제 및 의약품에 대한 관심이 높아지고 있습니다. 바이오해킹 커뮤니티, 장수 연구자, 웰빙 브랜드는 니코틴아미드리보사이드(NR)와 니코틴아미드 모노뉴클레오티드(NMN)와 같은 NAD 전구체의 인기를 주도하고 있습니다. 이들은 NAD 생성을 증가시켜 세포의 회복력을 향상시키는 것으로 알려져 있습니다. 노화 방지 치료, 신경 보호, 만성질환 관리에서 NAD 치료의 통합은 그 용도를 더욱 확대하여 생명 공학, 영양 보충제, 맞춤형 의료에서 중요한 관심 분야가 되었습니다. 장수 추구에 대한 관심이 높아지면서 NAD는 차세대 건강 혁명의 초석이 되고 있으며, 활력, 인지 기능 및 대사 효율을 개선하는 데 유망 이점을 제공합니다.

NAD 기반 제품 상용화에 영향을 미치는 과제는?

NAD에 대한 관심이 높아지고 있음에도 불구하고 NAD의 상업화 및 헬스케어 및 웰니스 용도로의 보급에 영향을 미치는 몇 가지 문제가 있습니다. 주요 우려 사항 중 하나는 NAD 부스트 보충제를 둘러싼 규제의 불확실성이며, 세계 보건기구는 아직 복용량, 안전성, 장기적 효과에 대한 명확한 가이드라인을 확립하지 못했습니다. NAD 전구체, 특히 NMN과 NR은 고가이기 때문에 많은 소비자의 이용이 제한되어 영양 보충제 시장에서 가격 설정의 장벽이 되고 있습니다. 과학적 회의론도 만만치 않으며, NAD는 전임상시험에서 가능성을 보였으나, 노화 회복과 만성질환 치료에 대한 효과를 검증하기 위해서는 대규모 인체 실험이 필요합니다. 또한 경구용 NAD 보충제는 흡수율이 다르기 때문에 정맥주사, 설하제제, 나노인캡슐레이션 기술 등 보다 효율적인 전달 메커니즘이 필요합니다. 시장은 또한 레스베라트롤, 코엔자임Q10, 스펠미딘 등 효능이 중복되는 대체 장수 보조제와의 경쟁 심화에도 직면해 있습니다. 이러한 문제를 해결하기 위해서는 추가 연구, 표준화된 임상 검증, 유효성, 경제성, 규제 준수를 보장하기 위한 NAD 제제의 발전이 필요합니다.

기술 혁신은 NAD 보충제와 치료법의 효과를 어떻게 향상시키고 있는가?

기술 발전과 과학적 연구는 NAD 보충제 및 치료 용도의 기술 혁신을 촉진하여 흡수, 효능 및 소비자 접근성을 향상시키고 있습니다. 가장 유망 개발 중 하나는 리포좀이나 나노인캡슐레이션된 NAD 전달 시스템을 도입하여 생체 이용률을 높이고 세포 내로 더 잘 흡수될 수 있도록 하는 것입니다. 정맥내 NAD 요법은 기능성 의학 클리닉에서 인기를 얻고 있으며, 노화 방지 효과, 인지 기능 강화, 신진대사 최적화를 원하는 사람들에게 NAD 수치의 빠른 회복을 제공합니다. 또한 NAD와 레스베라트롤, 프테로스틸벤, 서튜인 활성화 분자(STAC) 등의 시너지 화합물과의 병용은 장수와 세포 복구에 대한 효과를 높입니다. 맞춤형 영양학 및 유전자 검사의 부상도 NAD 보충을 최적화하는 데 일조하고 있으며, 기업은 개인의 대사 프로파일과 생활습관 요인에 기반한 맞춤형 프로토콜을 제공합니다. 신경 퇴행성 질환, 대사 장애, 면역 건강에 대한 NAD 강화제의 제약 연구는 그 의학적 가능성을 더욱 넓혀가고 있습니다. 세포 건강과 노화에 대한 NAD의 이점이 계속 입증됨에 따라 제형과 전달 방법의 혁신은 장수 및 웰니스 시장에서 새로운 가능성을 열어줄 것으로 보입니다.

NAD(Nicotinamide Adenine Dinucleotide) 시장의 성장 원동력은 무엇인가?

NAD 시장의 성장은 장수 및 노화 방지 솔루션에 대한 소비자의 관심 증가, 대사 건강에 대한 연구 증가, 생명공학 기술의 발전 등 여러 요인에 의해 이루어지고 있습니다. 바이오해킹 운동의 확산과 장수에 초점을 맞춘 웰빙 프로그램의 인기로 인해 NAD 보충제에 대한 수요가 증가하고 있으며, 소비자들은 에너지 대사, 인지 기능, 세포 회춘을 지원하는 제품을 적극적으로 찾고 있습니다. 알츠하이머, 심혈관 질환, 2형 당뇨병과 같은 노화 관련 질병을 예방할 수 있는 가능성이 있다고 보고 NAD를 이용한 치료법이 연구되고 있기 때문입니다. 정밀의료와 영양유전체학이 확대되면서 의료 서비스 프로바이더들이 NAD 보충제를 개인 맞춤형 건강 최적화 계획에 통합함으로써 시장 성장을 더욱 가속화하고 있습니다. 또한 DTC(Direct-to-Consumer) 웰니스 브랜드와 E-Commerce 플랫폼의 등장으로 NAD 기반 제품이 전 세계 사람들에게 더욱 친숙하게 다가갈 수 있게 되었습니다. 규제 프레임워크가 진화하고 과학적 검증이 강화됨에 따라 NAD 시장은 지속적으로 성장하고 건강, 장수, 대사 최적화의 미래에서 변혁적인 역할을 할 것으로 예측됩니다.

부문

등급 유형(식품 등급, 의약품 등급, 기타 등급 유형), 용도(식이보충제 용도, 의약품 용도, 안티에이징 제품 용도, 기타 용도)

조사 대상 기업의 예

  • Beijing Mesochem Technology Co., Ltd.
  • Bontac Bio-engineering Shenzhen
  • GIHI CHEMICALS CO., LIMITED
  • Hebei Miaoyin Technology Co., Ltd.
  • HRV Global Life Sciences
  • Huaian Banting Trading Co., Ltd.
  • Hubei Aoks Bio-tech Co., Ltd.
  • LGM Pharma
  • Mainchem Co., Ltd.
  • Maintain Biotech Co., Ltd.
  • Nuray Chemicals Private Limited
  • NutriScience Innovations LLC
  • Oxsyns Biotech
  • OYCUS
  • Shanghai Longyu Biotechnology Co., Ltd.
  • SIGMA TAU Pharmaceuticals, Inc.
  • Sinoway Industrial Co., Ltd.
  • Suvchem Laboratory Chemicals
  • SyncoZymes(Shanghai) Co., Ltd.
  • Wuhan Cell Pharmaceutical Co., Ltd.

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.08.18

Global Nicotinamide Adenine Dinucleotide Market to Reach US$1.4 Billion by 2030

The global market for Nicotinamide Adenine Dinucleotide estimated at US$683.1 Million in the year 2024, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 13.3% over the analysis period 2024-2030. Food Grade, one of the segments analyzed in the report, is expected to record a 14.8% CAGR and reach US$833.1 Million by the end of the analysis period. Growth in the Pharmaceutical Grade segment is estimated at 12.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$186.1 Million While China is Forecast to Grow at 18.1% CAGR

The Nicotinamide Adenine Dinucleotide market in the U.S. is estimated at US$186.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$310.8 Million by the year 2030 trailing a CAGR of 18.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.6% and 12.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR.

Global Nicotinamide Adenine Dinucleotide (NAD) Market - Key Trends & Drivers Summarized

Why Is Nicotinamide Adenine Dinucleotide (NAD) Gaining Prominence in Health and Longevity Research?

Nicotinamide adenine dinucleotide (NAD) has emerged as a critical molecule in the health and wellness industry due to its essential role in cellular metabolism, energy production, and DNA repair. As a coenzyme found in all living cells, NAD plays a key function in regulating mitochondrial function, oxidative stress response, and cellular aging processes. Scientific research has linked declining NAD levels with aging and age-related diseases, leading to increased interest in NAD-boosting supplements, therapies, and pharmaceuticals aimed at extending lifespan and enhancing metabolic health. Biohacking communities, longevity researchers, and wellness brands are driving the popularity of NAD precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), which are believed to enhance NAD production and improve cellular resilience. The integration of NAD therapies in anti-aging treatments, neuroprotection, and chronic disease management is further expanding its applications, making it a key focus area in biotechnology, nutraceuticals, and personalized medicine. As the pursuit of longevity gains momentum, NAD is becoming a cornerstone of the next-generation health revolution, offering promising benefits for improving vitality, cognitive function, and metabolic efficiency.

What Challenges Are Impacting the Commercialization of NAD-Based Products?

Despite the growing interest in NAD, several challenges impact its commercialization and widespread adoption in healthcare and wellness applications. One of the primary concerns is the regulatory uncertainty surrounding NAD-boosting supplements, as global health agencies have yet to establish clear guidelines on dosage, safety, and long-term effects. The high cost of NAD precursors, particularly NMN and NR, limits accessibility for many consumers, creating a pricing barrier in the nutraceutical market. Scientific skepticism also persists, as while NAD has demonstrated potential in preclinical studies, more extensive human trials are needed to validate its effectiveness in reversing aging or treating chronic diseases. Additionally, concerns over bioavailability pose a challenge, as oral NAD supplements have varying absorption rates, prompting the need for more efficient delivery mechanisms such as intravenous (IV) infusions, sublingual formulations, and nanoencapsulation technology. The market is also facing increasing competition from alternative longevity supplements, including resveratrol, coenzyme Q10, and spermidine, which offer overlapping benefits. Addressing these challenges will require further research, standardized clinical validation, and advancements in NAD formulation to ensure efficacy, affordability, and regulatory compliance.

How Are Innovations Enhancing the Effectiveness of NAD Supplements and Therapies?

Technological advancements and scientific research are driving innovation in NAD supplementation and therapeutic applications, improving absorption, efficacy, and consumer accessibility. One of the most promising developments is the introduction of liposomal and nanoencapsulated NAD delivery systems, which enhance bioavailability and allow for better cellular uptake. IV NAD therapy is gaining popularity in functional medicine clinics, offering rapid restoration of NAD levels for individuals seeking anti-aging benefits, cognitive enhancement, or metabolic optimization. Additionally, the combination of NAD with synergistic compounds such as resveratrol, pterostilbene, and sirtuin-activating molecules (STACs) is enhancing its effects on longevity and cellular repair. The rise of personalized nutrition and genetic testing is also playing a role in optimizing NAD supplementation, with companies offering tailored protocols based on an individual’s metabolic profile and lifestyle factors. Pharmaceutical research into NAD-boosting drugs for neurodegenerative diseases, metabolic disorders, and immune health is further expanding its medical potential. As research continues to validate the benefits of NAD in cellular health and aging, innovations in formulation and delivery methods are set to unlock new possibilities in the longevity and wellness markets.

What Is Driving the Growth of the Nicotinamide Adenine Dinucleotide (NAD) Market?

The growth in the NAD market is driven by several factors, including rising consumer interest in longevity and anti-aging solutions, increasing research into metabolic health, and advancements in biotechnology. The expanding biohacking movement and the popularity of longevity-focused wellness programs have fueled demand for NAD supplements, with consumers actively seeking products that support energy metabolism, cognitive function, and cellular rejuvenation. The aging global population is another key growth driver, as NAD-based therapies are being explored for their potential in preventing age-related diseases such as Alzheimer’s, cardiovascular disease, and type 2 diabetes. The expansion of precision medicine and nutrigenomics is further accelerating market growth, as healthcare providers integrate NAD supplementation into personalized health optimization plans. Additionally, the rise of direct-to-consumer (DTC) wellness brands and e-commerce platforms is making NAD-based products more accessible to a global audience. As regulatory frameworks evolve and scientific validation strengthens, the NAD market is expected to experience sustained growth, positioning it as a transformative player in the future of health, longevity, and metabolic optimization.

SCOPE OF STUDY:

The report analyzes the Nicotinamide Adenine Dinucleotide market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Grade Type (Food Grade, Pharmaceutical Grade, Other Grade Types); Application (Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Beijing Mesochem Technology Co., Ltd.
  • Bontac Bio-engineering Shenzhen
  • GIHI CHEMICALS CO., LIMITED
  • Hebei Miaoyin Technology Co., Ltd.
  • HRV Global Life Sciences
  • Huaian Banting Trading Co., Ltd.
  • Hubei Aoks Bio-tech Co., Ltd.
  • LGM Pharma
  • Mainchem Co., Ltd.
  • Maintain Biotech Co., Ltd.
  • Nuray Chemicals Private Limited
  • NutriScience Innovations LLC
  • Oxsyns Biotech
  • OYCUS
  • Shanghai Longyu Biotechnology Co., Ltd.
  • SIGMA TAU Pharmaceuticals, Inc.
  • Sinoway Industrial Co., Ltd.
  • Suvchem Laboratory Chemicals
  • SyncoZymes (Shanghai) Co., Ltd.
  • Wuhan Cell Pharmaceutical Co., Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Nicotinamide Adenine Dinucleotide - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Focus on Cellular Health and Longevity Throws the Spotlight on NAD+ Supplementation
    • Increasing Consumer Awareness of Anti-Aging Solutions Spurs Growth in NAD+ Products Market
    • Growing Interest in Biohacking Expands the Addressable Market Opportunity for NAD+ Therapies
    • Surge in Clinical Research on Mitochondrial Health Strengthens Business Case for NAD+
    • Advances in Nutraceutical Delivery Systems Drive Adoption of NAD+ Supplement Forms
    • Proliferation of Direct-to-Consumer Wellness Brands Accelerates Demand for NAD+ Supplements
    • Expansion of Preventive Healthcare Paradigms Propels Growth in NAD+-Based Interventions
    • Increased FDA and EMA Engagement with Aging-Related Therapies Shapes Regulatory Pathways for NAD+
    • Integration of NAD+ in Aesthetic and Cosmetic Applications Generates New Revenue Streams
    • Emerging Evidence Linking NAD+ with Cognitive Health and Neuroprotection Drives Therapeutic Exploration
    • Rapid Expansion of Personalized Nutrition and Genomics-Based Wellness Solutions Spurs NAD+ Innovation
    • Pharmaceutical Sector Investment in Age-Related Chronic Disease Therapies Boosts NAD+ Research Funding
    • Breakthroughs in NAD+ Precursors and Biosynthesis Pathways Expand Product Development Pipelines
    • High-Profile Endorsements and Celebrity-Driven Wellness Trends Accelerate NAD+ Market Awareness
    • Rising Geriatric Population Worldwide Sustains Long-Term Growth Potential for NAD+ Interventions
    • Integration of NAD+ in Sports Medicine and Athletic Recovery Regimens Drives Niche Demand
    • Collaborations Between Biotech Firms and Academic Research Institutions Strengthen the Innovation Ecosystem for NAD+
    • Escalating Global Burden of Metabolic Disorders and Diabetes Spurs Interest in NAD+ Modulation
    • Regulatory Ambiguity in Supplement Labeling and Claims Presents Challenges to Market Legitimacy
    • Regional Disparities in Healthcare Infrastructure and Consumer Access Create Uneven Growth Patterns for NAD+ Products
    • Digitally Enabled Health Tracking Tools Empower Consumers and Drive Demand for NAD+-Linked Performance Products
    • Entry of Big Pharma into the Longevity Sector Validates Market and Drives Competitive Intensity in NAD+ Space
    • Expansion of Online Health Retail Channels Amplifies NAD+ Product Reach and Consumer Accessibility
    • Rising Demand for Clean Label and Vegan-Friendly Formulations Shapes NAD+ Product Innovation
    • Emphasis on Evidence-Based Wellness Claims Drives Strategic Focus on Clinical Trials for NAD+ Products
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Nicotinamide Adenine Dinucleotide Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Nicotinamide Adenine Dinucleotide by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Food Grade by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Food Grade by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Food Grade by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pharmaceutical Grade by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pharmaceutical Grade by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Pharmaceutical Grade by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Grade Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Grade Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Grade Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Dietary Supplements Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Dietary Supplements Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Dietary Supplements Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Pharmaceuticals Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Pharmaceuticals Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Pharmaceuticals Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Anti-aging Products Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Anti-aging Products Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Anti-aging Products Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Nicotinamide Adenine Dinucleotide Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Nicotinamide Adenine Dinucleotide Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Nicotinamide Adenine Dinucleotide Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Nicotinamide Adenine Dinucleotide Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Nicotinamide Adenine Dinucleotide by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Nicotinamide Adenine Dinucleotide Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Nicotinamide Adenine Dinucleotide Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Nicotinamide Adenine Dinucleotide Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Nicotinamide Adenine Dinucleotide Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Nicotinamide Adenine Dinucleotide by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Nicotinamide Adenine Dinucleotide Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Nicotinamide Adenine Dinucleotide Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Nicotinamide Adenine Dinucleotide Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Nicotinamide Adenine Dinucleotide by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Nicotinamide Adenine Dinucleotide Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Nicotinamide Adenine Dinucleotide by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Nicotinamide Adenine Dinucleotide Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Nicotinamide Adenine Dinucleotide by Grade Type - Food Grade, Pharmaceutical Grade and Other Grade Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Grade Type - Percentage Breakdown of Value Sales for Food Grade, Pharmaceutical Grade and Other Grade Types for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Nicotinamide Adenine Dinucleotide by Application - Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Nicotinamide Adenine Dinucleotide by Application - Percentage Breakdown of Value Sales for Dietary Supplements Application, Pharmaceuticals Application, Anti-aging Products Application and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제